{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:30Z","timestamp":1786988190019,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ekir.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T14:02:45Z","timestamp":1493906565000},"page":"856-865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection\u2014A\u00a0Proof-of-Concept Study"],"prefix":"10.1016","volume":"2","author":[{"given":"Neil A.","family":"Hoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard T.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey L.","family":"Putt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Samaranayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.W.","family":"Schollum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2017.04.012_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/HYPERTENSIONAHA.110.164780","article-title":"Early sympathetic activation in the initial clinical stages of chronic renal failure","volume":"57","author":"Grassi","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib2","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2017.04.012_bib3","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2017.04.012_bib4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.25.4.878","article-title":"Renal afferent denervation prevents hypertension in rats with chronic renal failure","volume":"25","author":"Campese","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","article-title":"Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat","volume":"26","author":"Campese","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2017.04.012_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jch.12724","article-title":"Long-term effects of renal sympathetic denervation on hypertensive patients with mild to moderate chronic kidney disease","volume":"18","author":"Kiuchi","year":"2016","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ekir.2017.04.012_bib7","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","article-title":"Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension","volume":"33","author":"Ott","year":"2015","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ekir.2017.04.012_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in\u00a0moderate to severe CKD","volume":"23","author":"Hering","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib9","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.113.03098","article-title":"Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension","volume":"64","author":"Hering","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ckj\/sft130","article-title":"Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease","volume":"7","author":"Hoye","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2017.04.012_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCEP.110.937888","article-title":"Risk assessment for sudden cardiac death in dialysis patients","volume":"3","author":"Saravanan","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib12","first-page":"208","article-title":"Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment","volume":"22","author":"Penne","year":"2009","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib13","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2017.04.012_bib14","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2009111112","article-title":"Heart rate variability predicts ESRD and CKD-related hospitalization","volume":"21","author":"Brotman","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2007.10.033","article-title":"Prognostic value of heart rate variability in patients with renal failure on hemodialysis","volume":"131","author":"Oikawa","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib16","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1681\/ASN.V5122024","article-title":"The prognostic importance of left ventricular geometry in uremic cardiomyopathy","volume":"5","author":"Foley","year":"1995","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","article-title":"Norepinephrine and concentric hypertrophy in patients with end-stage renal disease","volume":"40","author":"Zoccali","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib18","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1681\/ASN.V12122759","article-title":"Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study","volume":"12","author":"London","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.jacc.2013.10.073","article-title":"Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction","volume":"63","author":"Schirmer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib21","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","article-title":"Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial","volume":"35","author":"Mahfoud","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2017.04.012_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2016.01.088","article-title":"Proof of concept study: improvement of echocardiographic parameters after renal sympathetic denervation in CKD refractory hypertensive patients","volume":"207","author":"Kiuchi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib23","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ndt\/gfs044","article-title":"Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patient","volume":"27","author":"Di Daniele","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.04.012_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jch.12017","article-title":"Renal denervation in a hypertensive patient with end-stage renal disease and small arteries: a direction for future research","volume":"14","author":"Ott","year":"2012","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.ekir.2017.04.012_bib25","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijcard.2011.05.022","article-title":"Catheter-based radiofrequency ablation therapy of the renal sympathetic-nerve system for drug resistant hypertension in a patient with end-stage renal disease","volume":"154","author":"Prochnau","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5152\/dir.2013.13408","article-title":"Technical aspects of renal denervation in end-stage renal disease patients with challenging anatomy","volume":"20","author":"Spinelli","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib27","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.ijcard.2013.01.218","article-title":"Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease","volume":"168","author":"Schlaich","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib28","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/ndt\/gfv311","article-title":"Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve)","volume":"30","author":"Schneider","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.04.012_bib29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/HJH.0b013e32833c20eb","article-title":"Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity","volume":"28","author":"Klein","year":"2010","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ekir.2017.04.012_bib30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.ekir.2017.04.012_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.ekir.2017.04.012_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1088\/0967-3334\/27\/9\/012","article-title":"Body fluid volume determination via body composition spectroscopy in health and disease","volume":"27","author":"Moissl","year":"2006","journal-title":"Physiol Meas"},{"key":"10.1016\/j.ekir.2017.04.012_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000167013","article-title":"Importance of whole-body bioimpedance spectroscopy for the management of fluid balance","volume":"27","author":"Wabel","year":"2009","journal-title":"Blood Purif"},{"key":"10.1016\/j.ekir.2017.04.012_bib35","doi-asserted-by":"crossref","first-page":"e17148","DOI":"10.1371\/journal.pone.0017148","article-title":"Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort","volume":"6","author":"Van Biesen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2017.04.012_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-201X.1968.tb10904.x","article-title":"Pulse and respiratory grouping of sympathetic impulses in human muscle-nerves","volume":"74","author":"Hagbarth","year":"1968","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ekir.2017.04.012_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1748-1716.1972.tb05158.x","article-title":"Manoeuvres affecting sympathetic outflow in human muscle nerves","volume":"84","author":"Delius","year":"1972","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ekir.2017.04.012_bib38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.ph.50.030188.003025","article-title":"Peripheral sympathetic neural activity in conscious humans","volume":"50","author":"Wallin","year":"1988","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0024-3205(81)90139-9","article-title":"Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man","volume":"28","author":"Goldstein","year":"1981","journal-title":"Life Sci"},{"key":"10.1016\/j.ekir.2017.04.012_bib40","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/clinchem\/32.11.2030","article-title":"Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase","volume":"32","author":"Eisenhofer","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/j.ekir.2017.04.012_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-123-2-199507150-00004","article-title":"Plasma metanephrines in the diagnosis of pheochromocytoma","volume":"123","author":"Lenders","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2017.04.012_bib42","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/eurheartj\/eht197","article-title":"Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial","volume":"34","author":"Worthley","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2017.04.012_bib43","series-title":"Bootstrapping: A Nonparametric Approach to Statistical Inference","author":"Mooney","year":"1993"},{"key":"10.1016\/j.ekir.2017.04.012_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.HYP.0000160318.46725.46","article-title":"Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity","volume":"45","author":"Narkiewicz","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.5.1.86","article-title":"Plasma catecholamines and essential hypertension: an analytical review","volume":"5","author":"Goldstein","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01826234","article-title":"Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade","volume":"3","author":"Fagius","year":"1993","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.ekir.2017.04.012_bib47","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1989.192","article-title":"Impact of left ventricular hypertrophy on survival in end-stage renal disease","volume":"36","author":"Silberberg","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.04.012_bib49","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.V1071606","article-title":"The clinical epidemiology of cardiac disease in chronic renal failure","volume":"10","author":"Parfrey","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.04.012_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2017.04.012_bib51","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1523-1755.2005.00527.x","article-title":"Prognostic value of 24-hour ambulatory blood pressure monitoring and of night\/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients","volume":"68","author":"Tripepi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.04.012_bib52","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","author":"Workgroup","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2017.04.012_bib53","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/ndt\/gfq175","article-title":"Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment","volume":"25","author":"Siddiqi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.04.012_bib54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.HYP.0000256530.39695.a3","article-title":"Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment","volume":"49","author":"Neumann","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib55","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/eurheartj\/ehu127","article-title":"Renal denervation and regression of left ventricular hypertrophy","volume":"35","author":"Bruno","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2017.04.012_bib56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/HYPERTENSIONAHA.113.02144","article-title":"Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation","volume":"63","author":"Schlaich","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/HYPERTENSIONAHA.113.01261","article-title":"Translational examination of changes in baroreflex function after renal denervation in hypertensive rats and humans","volume":"62","author":"Hart","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ekir.2017.04.012_bib58","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/eurheartj\/ehu091","article-title":"Renal denervation for hypertension: observations and predictions of a founder","volume":"35","author":"Esler","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2017.04.012_bib59","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.jacc.2013.08.1616","article-title":"International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension","volume":"62","author":"Schlaich","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ekir.2017.04.012_bib60","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/eurheartj\/ehv192","article-title":"Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design","volume":"36","author":"Mahfoud","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2017.04.012_bib61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajh\/hpw012","article-title":"Sympathomodulatory Effects of antihypertensive drug treatment","volume":"29","author":"Grassi","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ekir.2017.04.012_bib62","doi-asserted-by":"crossref","first-page":"937398","DOI":"10.1155\/2014\/937398","article-title":"Heart failure in patients with chronic kidney disease: a systematic integrative review","volume":"2014","author":"Segall","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ekir.2017.04.012_bib63","first-page":"569","article-title":"Potential future denervation targets","volume":"6","author":"Leong","year":"2014","journal-title":"Int J Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2017.04.012_bib64","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2215\/CJN.04860709","article-title":"Left ventricular mass in chronic kidney disease and ESRD","volume":"4","author":"Glassock","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917301110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917301110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T02:45:10Z","timestamp":1658976310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024917301110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2468024917301110"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2017.04.012","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection\u2014A\u00a0Proof-of-Concept Study","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}